Vandortuzumab (Anti-STEAP1)
Vandortuzumab (Anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer. MW : 145.5 KD.
| Catalog Number | A2343 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/vandortuzumab-anti-steap1.html |